Evidence map›Paper›PMID 23345296›Full record

ArticleJournal of clinical microbiology2013

Microplate alamarBlue assay for Paracoccidioides susceptibility testing.

A C A de Paula e Silva, H C Oliveira, J F Silva, F Sangalli-Leite, L Scorzoni, A M Fusco-Almeida, M J S Mendes-Giannini

Abstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Antifungal activity of guanidine compounds.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  2. Article
  3. Peptides fromFuture microbiology · 2025
    Article
  4. Resazurin to determine the minimum inhibitory concentration on antifungal susceptibility assays for Fonsecaea sp. using a modified EUCAST protocol.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  5. Article
  6. Role of paracoccin onVirulence · 2023
    Article
  7. Polypeptides TargetingJournal of fungi (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Evaluation of the Anti-Pharmaceutics · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. In Vitro and In Vivo Effect of Peptides Derived from 14-3-3Journal of fungi (Basel, Switzerland) · 2021
    Article
  14. AIMS microbiology · 2021
    Article
  15. Review
  16. Antifungal Drug Repurposing.Antibiotics (Basel, Switzerland) · 2020
    Article
  17. Antifungal activity of liriodenine on agents of systemic mycoses, with emphasis on the genusThe journal of venomous animals and toxins including tropical diseases · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

A C A de Paula e SilvaFaculdade de Ciências Farmacêuticas, UNESP-Universidade Estadual Paulista, Araraquara, Departamento de Analises Clinicas, Laboratório de Micologia Clínica, São Paulo, Brazil.
H C Oliveira
J F Silva
F Sangalli-Leite
L Scorzoni
A M Fusco-Almeida
M J S Mendes-Giannini

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CLSI method M27-A3 is not available for use with dimorphic fungi, such as those of the Paracoccidioides genus. In this study, we developed a microdilution method and added the alamarBlue reagent to test the responses of Paracoccidioides brasiliensis and Paracoccidioides lutzii against amphotericin B and itraconazole antifungals. The test proved to be sensitive, practical, and inexpensive and can be used to monitor the activity of low-growth microorganisms and their response to various drugs.

Indexed as

Amphotericin BAntifungal AgentsHumansItraconazoleMicrobial Sensitivity TestsOxazinesParacoccidioidesStaining and LabelingXanthenesAmphotericin BAntifungal AgentsItraconazoleOxazinesresazurinXanthenes

Identifiers

PMID23345296
PMCPMC3666786

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.